Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Future Oncology (London, England)|June 11, 2024
Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinomaYongsik Sim, Beomseok Sohn, Sooyon Kim, et al.
Cancer Medicine|September 16, 2021
A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinomaJi Hyun Lee, Seong Gu Heo, Beung-Chul Ahn, et al.
Oncology|September 12, 2012
Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancerJae-Heon Jeong, Sun Min Lim, Ji Young Yun, et al.
Gut and Liver|March 1, 2012
A case of synchronous squamous cell carcinoma in the esophagus and stomachSun Min Lim, Eun Suk Jung, Sung Kwan Shin, et al.
Plos One|July 25, 2014
Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangementsYoon Jin Cha, Jae Seok Lee, Hye Ryun Kim, et al.
Cancers|August 7, 2021
Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World StudyBeung-Chul Ahn, Jee Hung Kim, Kyoung-Ho Pyo, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer modelsKyoung Ho Pyo, Jae Hwan Kim, Ji-Min Lee, et al.
Frontiers in Oncology|March 21, 2022
The Development of AXL Inhibitors in Lung Cancer: Recent Progress and ChallengesYun Beom Sang, Joo-Hang Kim, Chang-Gon Kim, et al.
Plos One|September 15, 2015
Lack of ROS1 Gene Rearrangement in Glioblastoma MultiformeSun Min Lim, Junjeong Choi, Jong Hee Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 27, 2023
Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter studyHyunwook Kim, Beung-Chul Ahn, Jiyun Lee, et al.
Pageof 14